VEGFA and preeclampsia: One of the pivotal breakthroughs in the understanding of preeclampsia was the recognition of increased circulating levels of the vascular endothelial growth factor (VEGF) antagonist sFlt-1 in the circulation of preeclampsia patients (Maynard et al., 2003).